by Gould, T.D. et al.
Laboratory of Molecular Pathophysiology and Experimental Therapeutics, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
Laboratory of Molecular Pathophysiology and Experimental Therapeutics, National Institute of Mental Health, National Institutes of Health, Bethesda, USA
Regulating beta-catenin may modulate drug effects rather than being a model of mood disorder pathophysiology per se.
Behav. Brain Res. 2008; 1:117-25